Unit of Urology, Spedali Civili Hospital, University of Brescia, Brescia, Italy.
Unit of Urology, Spedali Civili Hospital, University of Brescia, Brescia, Italy.
Clin Genitourin Cancer. 2019 Feb;17(1):e26-e31. doi: 10.1016/j.clgc.2018.08.004. Epub 2018 Aug 23.
The role of positive surgical margins (PSMs) on the recurrence of renal cell carcinoma (RCC) after partial nephrectomy (PN) is debated, and available evidence lacks long-term data. The aim of this study was to evaluate the predictive role of PSMs on progression-free survival (PFS) in a large cohort followed for at least 5 years.
This study was a retrospective analysis of a prospectively compiled single-institution database collecting complete information on more than 2700 patients who had undergone surgery for renal tumor. The data of all the patients submitted to PN for RCC and with least 5 years follow-up were extracted. Surgical specimens were examined at the time of surgery only by 2 expert uro-pathologists. A PSM was defined as the presence of cancer cells at the inked surface of the specimen. The role of PSMs on survival was estimated by Cox regression models adjusted for influent covariates.
A total of 459 patients fulfilled the inclusion criteria and were evaluated. PSMs were observed in 27 (5.9%) cases. No differences in preoperative and pathologic data were found comparing patients with and without PSMs. At a median follow-up of 96 months (interquartile range, 74-131 months), a clinically evident relapse of RCC was diagnosed in 36 (7.8%) patients at a median interval of 36 months from PN. Among these, 6 had a PSM for an incidence of relapse of 22.2% in the PSM group, whereas 30 had negative margins, for an incidence of 6.9% (P = .013). The sites of relapse were distant organs in 18 cases, and the kidney underwent PN in 21. The patients with PSMs showed a borderline significantly higher incidence of distant metastasis (11.1% vs. 3.5%; P = .071) and a significantly higher incidence of renal relapses (14.8% vs. 3.9%; P = .029). Multivariable Cox models confirmed that the presence of PSMs was an independent predictor of PFS (odds ratio, 3.127; P = .013).
PSMs are an independent predictor of PFS in patients who underwent PN for RCC, owing to a higher incidence of distant and local relapses. Surveillance in presence of PSMs should be intensified and extended for a long time.
部分肾切除术 (PN) 后阳性切缘 (PSM) 对肾细胞癌 (RCC) 复发的作用存在争议,现有证据缺乏长期数据。本研究旨在评估 PSM 在至少随访 5 年的大样本队列中对无进展生存期 (PFS) 的预测作用。
这是一项回顾性分析,对一个前瞻性收集的单机构数据库进行分析,该数据库收集了 2700 多名接受肾肿瘤手术的患者的完整信息。提取所有接受 RCC 行 PN 且随访时间至少 5 年的患者的数据。手术标本仅由 2 名专家泌尿病理学家在手术时进行检查。PSM 定义为标本上墨迹表面有癌细胞。通过 Cox 回归模型调整影响因素,估计 PSMs 对生存的影响。
共有 459 例患者符合纳入标准并进行了评估。27 例(5.9%)患者存在 PSM。比较有和无 PSM 的患者,术前和病理数据无差异。在中位随访 96 个月(四分位间距,74-131 个月)时,PN 后中位时间 36 个月诊断出 36 例(7.8%)RCC 临床明显复发。其中,6 例 PSM 复发率为 22.2%,30 例无 PSM 复发率为 6.9%(P =.013)。复发部位为远处器官 18 例,肾脏行 PN 21 例。PSM 组远处转移发生率(11.1% vs. 3.5%;P =.071)和肾脏复发发生率(14.8% vs. 3.9%;P =.029)有边缘显著升高。多变量 Cox 模型证实,PSM 的存在是 PFS 的独立预测因子(优势比,3.127;P =.013)。
PSM 是 RCC 患者行 PN 后 PFS 的独立预测因子,原因是远处和局部复发的发生率更高。存在 PSM 时应加强和延长监测时间。